Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Shares Outstanding (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Shares Outstanding for 2 consecutive years, with $17.7 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Outstanding rose 67.99% year-over-year to $17.7 million, compared with a TTM value of $17.7 million through Jun 2025, up 67.99%, and an annual FY2024 reading of $13.7 million, changed N/A over the prior year.
  • Shares Outstanding was $17.7 million for Q2 2025 at Kairos Pharma, up from $15.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $17.7 million in Q2 2025 and bottomed at $10.6 million in Q1 2024.